secwatch.observer — SEC 8-K summary
======================================

Issuer:     Privia Health Group, Inc. (PRVA)
CIK:        0001759655
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001759655-25-000080
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Privia Health appoints Lance Berberian to board, adds tech and cybersecurity expertise
--------------------------------------------------------------------------------

- Appointed Lance Berberian to Class III director, effective July 15, 2025; board expands to 10 members.
- Berberian brings 30+ years tech strategy experience, most recently EVP & CIO at Labcorp Holdings (NYSE: LH).
- Will receive annual cash retainer per non-employee director plan and $200K initial RSU grant prorated.
- Also named to Audit Committee; qualifies as independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759655/000175965525000080/0001759655-25-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759655/000175965525000080/prva-20250703.htm
  HTML page:      https://secwatch.observer/filing/0001759655-25-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer